Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Disease Progression and NODAL[original query] |
|---|
| Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery 2003 Sep 134 (3): 425-31. Machens Andreas, Holzhausen Hans-Jürgen, Thanh Phuong Nguyen, Dralle Henni |
| Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma. Pigment cell & melanoma research 2014 Nov 27 (6): 1117-25. Mar Victoria J, Wong Stephen Q, Logan Aleksandra, Nguyen Trung, Cebon Jonathan, Kelly John W, Wolfe Rory, Dobrovic Alexander, McLean Catriona, McArthur Grant |
| Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. Thyroid : official journal of the American Thyroid Association 2016 Sep . Grubbs Elizabeth G, Williams Michelle D, Scheet Paul, Vattathil Selina, Perrier Nancy, Lee Jeffrey E, Gagel Robert F, Hai Tao, Feng Lei, Cabanillas Maria, Cote Gilbert |
| IL-10 and integrin signaling pathways are associated with head and neck cancer progression. BMC genomics 2016 17 (1): 38. Bornstein Sophia, Schmidt Mark, Choonoo Gabrielle, Levin Trevor, Gray Joe, Thomas Charles R, Wong Melissa, McWeeney Shann |
| Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. BMC cancer 2017 Aug 17 (1): 536. Heppt Markus V, Siepmann Timo, Engel Jutta, Schubert-Fritschle Gabriele, Eckel Renate, Mirlach Laura, Kirchner Thomas, Jung Andreas, Gesierich Anja, Ruzicka Thomas, Flaig Michael J, Berking Caro |
| Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC). Acta oncologica (Stockholm, Sweden) 2018 6 57 (11): 1567-1573. von Reibnitz Donata, Shaikh Fauzia, Wu Abraham J, Treharne Gregory C, Dick-Godfrey Rosalind, Foster Amanda, Woo Kaitlin M, Shi Weiji, Zhang Zhigang, Din Shaun U, Gelblum Daphna Y, Yorke Ellen D, Rosenzweig Kenneth E, Rimner Andre |
| DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients. Melanoma research 2019 Apr . Maric Helena, Supic Gordana, Kandolf-Sekulovic Lidija, Maric Veljko, Mijuskovic Zeljko, Radevic Tatjana, Rajovic Milica, Magic Zvon |
| Expression of oestrogen-? receptor in papillary thyroid carcinoma and its association with metastasis. The Malaysian journal of pathology 2020 12 42 (3): 415-422. Ab Halim S A, Lee S K, Mustangin M, Mohd Saleh M F, Shah S A, Md Isa |
| Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy. Frontiers in oncology 2021 11 736769. Lin Po-Han, Wang Ming-Yang, Lo Chiao, Tsai Li-Wei, Yen Tzu-Chun, Huang Thomas Yoyan, Huang Wei-Chih, Yang Karen, Chen Chih-Kai, Fan Sheng-Chih, Kuo Sung-Hsin, Huang Chiun-She |
| Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 1 40 (11): 1196-1205. Giné Eva, de la Cruz Fátima, Jiménez Ubieto Ana, López Jimenez Javier, Martín García-Sancho Alejandro, Terol M José, González Barca Eva, Casanova María, de la Fuente Adolfo, Marín-Niebla Ana, Muntañola Ana, González-López Tomás José, Aymerich Marta, Setoain Xavier, Cortés-Romera Montserrat, Rotger Amanda, Rodríguez Sonia, Medina Herrera Alejandro, García Sanz Ramón, Nadeu Ferran, Beà Silvia, Campo Elías, López-Guillermo Arman |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: